Stock BYSI BEYONDSPRING INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BeyondSpring Inc.

Equities

BYSI

KYG108301006

Market Closed - Nasdaq
Other stock markets
 02:00:01 04/05/2024 am IST 		5-day change 1st Jan Change
2.25 USD +4.16% Intraday chart for BeyondSpring Inc. +5.63% +150.00%
29/04 North American Morning Briefing : Investors Brace -2- DJ
22/04 North American Morning Briefing : Stock Futures -2- DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
AQ
BeyondSpring Files 2023 Annual Report on Form 20-F
AQ
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
AQ
North American Morning Briefing : Investors Brace -2-
DJ
North American Morning Briefing : Stock Futures -2-
DJ
North American Morning Briefing : Stock Futures -2-
DJ
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment
MT
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
AQ
Beyondspring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in A Phase 2 Investigator-Initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
CI
BeyondSpring Inc. Announces Executive Changes
CI
Top Premarket Decliners
MT
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements
AQ
BeyondSpring Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
BeyondSpring Receives Non-Compliance Notice From Nasdaq
MT
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
AQ
BeyondSpring Receives Notification From Nasdaq for Breaching Minimum Bid Price Requirements
MT
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
AQ
Transcript : BeyondSpring Inc. - Special Call
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors
AQ
BeyondSpring Inc. Announces New Data That Translates Preclinical Proof-Of-Concept to Clinical Evidence of Plinabulin?s Immunomodulating Activity
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BYSI Stock
  4. News BeyondSpring Inc.